Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
106.99
-5.20 (-4.63%)
Mar 9, 2026, 3:10 PM IST
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 2.53 billion as of March 9, 2026. Its market cap has increased by 36.14% in one year.
Market Cap
2.53B
Enterprise Value
2.85B
Revenue
1.47B
Ranking
n/a
PE Ratio
26.18
Stock Price
106.99
Market Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 2.53B, an increase of 23,158.69%. That is a compound annual growth rate of 147.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valiant Laboratories | 2.90B |
| Nectar Lifesciences | 2.27B |
| Brooks Laboratories | 1.80B |
| Alpa Laboratories | 1.34B |
| Par Drugs and Chemicals | 1.13B |
| Sigachi Industries | 7.31B |
| Vaishali Pharma | 879.31M |
| Beta Drugs | 11.08B |